Adam Bass

Title: The Innovative Contributions of Adam Bass

Introduction

Adam Bass is a prominent inventor based in Somerville, MA (US). He has made significant contributions to the field of cancer research, particularly through his innovative patents. With a total of 2 patents, Bass is recognized for his work in developing new methods and compositions for cancer treatment.

Latest Patents

One of Adam Bass's latest patents is titled "Compositions and methods for treating cancer using RHOA dominant negative forms." This invention provides compositions and methods for treating cancers with reduced or absent CDH1 using a RHOA dominant negative polypeptide or biologically active fragment thereof, and/or a nucleic acid encoding a RHOA dominant negative polypeptide or biologically active fragment thereof. Another significant patent is "PD-L2 biomarkers predictive of PD-1 pathway inhibitor responses in esophagogastric cancers." This invention is based on the identification of novel biomarkers predictive of responsiveness of esophagogastric cancers to inhibitors of the PD-1 pathway.

Career Highlights

Adam Bass is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research and innovations in cancer treatment. His work has garnered attention in the scientific community for its potential impact on patient care and treatment outcomes.

Collaborations

Some of his notable coworkers include Scott J. Rodig and Sarah Derks, who collaborate with him on various research projects aimed at improving cancer therapies.

Conclusion

Adam Bass's contributions to cancer research through his patents and collaborations highlight his commitment to innovation in the medical field. His work continues to pave the way for new treatment options for patients facing cancer.